STAAR Surgical Company

STAA Healthcare Medical Instruments & Supplies

In the quarter to June 2026, revenue grew 111.0%, EPS grew 147.1% and free cash flow grew 166.1%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

21.27 0.99 −4.45%
Market cap
$1.1B
P/E
304×
Fwd P/E
103×
Dividend yield
—
F-score
2/9
Altman Z
6.44
Beneish M
−3.29
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
Piotroski F-Score

+8 more TTM periods

2 1 4 5
ROE
(24.65%) (21.70%) (5.99%) 1.09%
ROA
(19.39%) (16.74%) (4.63%) 0.84%
ROIC
(37.54%) (30.31%) (7.49%) 4.67%
Return on Tangible Assets
(29.01%) (25.43%) (6.51%) 1.13%
Average Days of Receivables
95.14 76.32 102.03 105.84
Free Cash Flow per Share
(0.80) (0.81) (1.10) (0.13)
Free Cash Flow
(39.54) (40.05) (54.99) (6.75)
Other line items

Show all line items

Columns are period end dates